[Federal Register: December 27, 2007 (Volume 72, Number 247)]
[Notices]               
[Page 73369]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27de07-87]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated September 12, 2007, and published in the Federal 
Register on September 19, 2007 (72 FR 53606), Research Triangle 
Institute, Kenneth H. Davis Jr., Hermann Building, P.O. Box 12194, East 
Institute Drive, Research Triangle, North Carolina 27709, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of the basic classes of controlled 
substances listed in schedules I and II:

----------------------------------------------------------------------------------------------------------------
                      Drug                                                   Schedule
----------------------------------------------------------------------------------------------------------------
Marihuana (7360)...............................  I
Cocaine (9041).................................  II
----------------------------------------------------------------------------------------------------------------

    The Institute will manufacture small quantities of cocaine and 
marihuana derivatives for use by their customers in analytical kits, 
reagents, and reference standards as directed by NIDA.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Research Triangle Institute to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Research Triangle Institute to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: December 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-25047 Filed 12-26-07; 8:45 am]

BILLING CODE 4410-09-P